{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:13Z","timestamp":1786119493965,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/jcp.0b013e3181db2684","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T04:28:32Z","timestamp":1273033712000},"page":"282-285","source":"Crossref","is-referenced-by-count":53,"title":["Hematological Effects of Valproate in Psychiatric Patients"],"prefix":"10.1097","volume":"30","author":[{"given":"Kamini","family":"Vasudev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Keown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Hamish","family":"McAllister-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate.","volume":"22","author":"Acharya","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.","volume":"23","year":"2009","journal-title":"J Psychopharmacol"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2009.05.030","article-title":"Onset-age of bipolar disorders at six international sites.","volume":"121","author":"Baldessarini","year":"2010","journal-title":"J Affect Disord"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic Catchment Area (ECA) Study.","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.150.1.108","article-title":"Suicidal behaviours in adult psychiatric outpatients, I: description and prevalence.","volume":"150","author":"Asnis","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/026988110101500305","article-title":"Pharmacokinetics of valproic acid in patients with bipolar disorder.","volume":"15","author":"Vasudev","year":"2001","journal-title":"J Psychopharmacol"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/appi.ajp.158.1.128","article-title":"Occurrence of thrombocytopenia in psychiatric patients taking valproate.","volume":"158","author":"Trannel","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.jcp.0000088911.24613.0d","article-title":"Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.","volume":"23","author":"De Berardis","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1592\/phco.21.17.1325.34418","article-title":"Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital.","volume":"21","author":"Conley","year":"2001","journal-title":"Pharmacotherapy"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/088307389400900318","article-title":"Thrombocytopenia secondary to high valproate levels in children with epilepsy.","volume":"9","author":"Delgado","year":"1994","journal-title":"J Child Neurol"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","article-title":"Valproate-induced thrombocytopenia: a prospective monotherapy study.","volume":"49","author":"Nasreddine","year":"2008","journal-title":"Epilepsia"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1176\/ajp.152.3.413","article-title":"Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2228 patients at risk.","volume":"152","author":"Tohen","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomised, placebo-controlled 12 month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder.","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania.","volume":"159","author":"Tohen","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2710.1993.tb00612.x","article-title":"Plasma protein binding kinetics of valproic acid over a broad range: therapeutic implications.","volume":"18","author":"Gomez Bellver","year":"1993","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.","volume":"8","author":"Warkentin","year":"2006","journal-title":"Blood"},{"issue":"1","key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0939-6411(01)00151-5","article-title":"Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.","volume":"52","author":"Kodama","year":"2001","journal-title":"Eur J Pharm Biopharm"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania.","volume":"48","author":"Pope","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.153.6.765","article-title":"Relation of serum valproate concentration to response in mania.","volume":"153","author":"Bowden","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v64n0717","article-title":"The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1176\/appi.ajp.163.2.272","article-title":"Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.","volume":"163","author":"Allen","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"6","key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1528-1157.1993.tb02139.x","article-title":"Haematologic manifestations of long-term valproate therapy.","volume":"34","author":"May","year":"1993","journal-title":"Epilepsia"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e3181db2684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:17:46Z","timestamp":1786040266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201006000-00010"}},"subtitle":["What Are the Risk Factors?"],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181db2684","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}